We also investigated the predictive value of Cdk5 through analysis of the association between tumor protein expression and the outcome of metastatic CRC patients receiving two standard chemotherapy regimens: Oxaliplatin plus 5-fluorouracil and irinotecan plus 5-fluorouracil. The gene discussed is CDK5; the disease is colorectal carcinoma.